Trials / Completed
CompletedNCT01456572
Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the reciprocal control between gastric functions and intestinal parameters in the development of satiation in obese people.
Detailed description
Obesity has reached pandemic proportions, obesity-associated complications are extensive and the current treatment options are limited. These facts demonstrate the need for an improved understanding of the pathogenesis of obesity. The gastrointestinal tract plays a key element in the control of satiation; discrepancies exist, however, for the role of gastric and intestinal parameters in the control of satiation in relation to body mass. To achieve a comprehensive understanding for the reciprocal control between gastric functions and intestinal parameters in the development of satiation in obese people the investigators will compare satiation parameters, gastric emptying and plasma glucagon-like peptide-1 (GLP-1), peptide tyrosine tyrosine (PYY) and ghrelin levels between normal and obese healthy volunteers. Time needed to reach the level of satiation and total calorie intake will be measured by a standardized nutrient drink test; gastric emptying of solids by a 13C-octanoic acid breath test; and plasma GLP-1, PYY and ghrelin levels will be measured after a standardized nutrient drink.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | ensure plus | 17 % protein, 30 % fat and 53 % carbohydrate; 1 kcal/mL |
| DIETARY_SUPPLEMENT | standardized test meal | scrambled eggs, two slices of whole wheat bread, 200 mL of milk and labeled with 13C-octanoic acid |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2011-02-01
- Completion
- 2011-07-01
- First posted
- 2011-10-20
- Last updated
- 2011-10-20
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01456572. Inclusion in this directory is not an endorsement.